TABLE 2.
Cefazolin MIC distribution among M. tuberculosis clinical isolates. Isoniazid and rifampin were used at a single drug concentration to reconfirm the drug-susceptible or MDR-TB status. Cefazolin MIC50 (in combination with avibactam) for the clinical isolates was 2 mg/L, whereas MIC90 was calculated as 8 mg/L.
| Clinical strain | Rifampin (1 mg/L) | Isoniazid (0.1 mg/L) | Cefazolin [with 15 mg/L avibactam] |
|---|---|---|---|
| 1A | S | S | 2 |
| 3A | S | S | 2 |
| 6B | S | S | 4 |
| 7A | S | S | 2 |
| 8A | S | S | 8 |
| 10B | S | S | 2 |
| 18B | S | S | 4 |
| 3D3 | R | R | 4 |
| 6C | R | R | 8 |
| 7C4 | R | R | 2 |
| 9C | R | R | 2 |
| 11D1 | R | R | 2 |
| 12D4 | R | R | 8 |
| 16D | R | R | 2 |
| 18D3 | R | R | 2 |
| 20D2 | R | R | 2 |
| 14C3 | R | R | 2 |
S, sensitive; R, resistant.